Search
Retinal_Health_DR infographic.pdf
Collaboration In Healthcare
Dr. V. Mohan Releases 9-point Action for People with Diabetes
Dr V. Mohan has released a 9-point action plan to ensure health for people with diabetes. Click here to read the press release and find out more.
The power of our people
Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity; a key element of our culture. Click here to find out more information.
COVID-Relief-India-2021
Boehringer Ingelheim prioritises life continuity to the underserved, in addition to medical aid. Click here to find out and learn more information.
Patient Centricity
At Boehringer Ingelheim, we put patients first in everything we do. Click here to learn more about patient centricity at Boehringer Ingelheim.
International Women's Day
We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”. Find out more here.
Our Responsibility
Our responsibility here at Boehringer Ingelheim to our patients is by serving people through research into diseases with unmet needs. Learn more here.
About Chronic Kidney Disease
Find out more about chronic kidney disease, it’s causes and symptoms
Our Global Support Program
Our Global Support Program aims to bring more financial relief, protective materials and more to healthcare institutions and communities in need.
Heart Diseases
Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.
A beginner’s guide to fighting off cat parasites
Prof. Donato Traversa explains the risk of multiparasitic infections and/or infestations in cats. Click here to read and find out more information.
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
Interview: Excellence in stem cell treatments
Acquisition of GST reflects the enormous potential of biotechnology research to provide breakthrough therapies for major diseases. Learn more.
Our Employees
We offer our employees demanding and challenging tasks. Boehringer Ingelheim needs employees who innovate. Learn more about our employees here.
History video
The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer in Nieder-Ingelheim. Watch the video here to learn more.
In France, it’s time to be(e)
How about producing honey and contributing to environmental sustainability during your work hours? Click here to read more about this story.
A Unique Bond: by my side
Caroline’s remarkable bond with Snowball helped her cope better with COPD and maintain a more independent life. Click here to watch the video.
COVID-19 Collaboration with Cantaro Azul in Mexico
Boehringer Ingelheim Mexico is collaborating with the NGO Cántaro Azul to provide hand sanitisers to people without access to clean water. Learn more here.
Afrika Kommt! - The Ripple Effect
What the Afrika Kommt! Fellowship Program means to Boehringer Ingelheim
COVID-19 France Production of hydroalcoholic-gel
We have launched production of our first hydro-alcoholic solution for internal use to help battle COVID-19. Click here to find out and learn more.
cat dog flea allergy dermatitis
Find out how you can identify and treat flea allergy dermatitis, one of the most common illnesses associated with a flea infestation. Learn more here.
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease
Jardiance® (empagliflozin) now approved in India
best-practice-innovative-Corporate-Citizenship-survey
Boehringer Ingelheim is named best practice example for innovative Corporate Citizenship in Germany by CC-survey. Click here to learn more about this.